We are live on ! Find out more
CMRX

Chimerix, Inc.

Delisted

CMRX was delisted on the 17th of April, 2025.

78 hedge funds and large institutions have $41.1M invested in Chimerix, Inc. in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

3% more funds holding

Funds holding: 7678 (+2)

4% more capital invested

Capital invested by funds: $39.5M → $41.1M (+$1.65M)

40% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 25

53% less call options, than puts

Call options by funds: $20K | Put options by funds: $43K

Holders
78
Holders Change
+2
Holders Change %
+2.63%
% of All Funds
1.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
15
Reduced
25
Closed
13
Calls
$20K
Puts
$43K
Net Calls
-$23K
Net Calls Change
-$21K

CMRX Hedge Fund Activity: Q1 2024 in Review

78 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q1 2024, worth a combined $41.1M — up 4.2% from $39.5M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CMRX positions and 13 closed out — a net gain of 2 holders — while 15 added to existing stakes and 25 trimmed.

The largest buyer was Acuitas Investments, adding an estimated $332K. The largest seller was Morgan Stanley, cutting an estimated $728K.

  • 78 institutional investors held Chimerix, Inc. (CMRX) as of Q1 2024, up from 76 in Q4 2023.
  • Funds reported $41.1M of Chimerix, Inc. stock for Q1 2024, up 4.2% quarter-over-quarter.
  • 15 funds opened new Chimerix, Inc. positions in Q1 2024 and 13 closed out, a net change of +2 holders.
  • The largest Chimerix, Inc. buyer in Q1 2024 was Acuitas Investments, an estimated $332K added.
  • The largest Chimerix, Inc. seller in Q1 2024 was Morgan Stanley, an estimated $728K sold.

Based on aggregated 13F filings for Q1 2024.